Posts

May is Brain cancer awareness month

According to Global Cancer Observatory (www.gco.iarc.fr), #braincancer contributed to 2.4% of all cancers in India during 2020. They ranked 14th in the number of cases (31,460), but 10th in the number of deaths (26656) due to cancers in 2020.
To tackle this deadly cancer, Sapien has collated FFPE blocks, flash frozen #tissue, live primary cells from many #braintumors to enable #drugscreening, validation of new #drugtargets and #glioma #biomarkers.
We will be sharing our brain cancer research and resources through May, starting with this slide on our #FFPE blocks with matched #RWE data from 1 of our many hospitals.

www.indiancancersociety.org; www.cancer.gov/types/brain;

Whatever your future psoriasis research needs – An image study, AI, Digital pathology, data analysis, biomarker analysis, drugs screening – we are here to help you

 

  • Despite relatively high prevalence of psoriasis at 0.4 to 2.8 % in the Indian population and availability of many treatment options, India is behind in psoriasis disease management1.
  • Research done on specific ethnic backgrounds and data from one population is not a global solution. Hence it has been recommended by WHO’s global report on Psoriasis, that Psoriasis research should focus on specific ethnicity and therapeutics that are unique to a specific population 2.
  • There is an increasing demand for crucial studies addressing definitive curative therapies.

 

Hence, well-conducted research specific to Indian population considering the differences in genetic makeup, environmental influences and health care costs could go a long way in improving the healthcare services for the psoriasis patients 3.

  1. Thappa DM, Munisamy M. Research on psoriasis in India: Where do we stand? Indian J Med Res. 2017;146(2):147-149. doi: 10.4103/ijmr.IJMR_1296_17
  1. https://apps.who.int/iris/bitstream/handle/10665/204417/9789241565189_eng.pdf.psoriasis;jsessionid=54912784D28C9F36ECCD45471AC5775B?sequence=1
  2. Dogra S, Mahajan R. Psoriasis: Epidemiology, clinical features, co-morbidities, and clinical scoring. Indian Dermatol Online J. 2016; 7:471–80

Sapien will be able to provide – Just what you need for your Psoriasis study

Sapien provides tailor-made biosample services adhering to IRB/IEC approved specimen collection protocols, and patient informed consent forms, and coding patient information to protect privacy.

  1. Sample types available – Blood, tissue punch samples, other biofluids.
  2. Ideal patient and sample requirements – Treated or treatment naïve, type of psoriasis, collection tubes/anticoagulant, processing e.g., blood to serum or plasma, PBMCs or DNA, quantity, molecular cellular IHC assays, H&E images
  3. Clinical Annotation – The exact type of data needed that you need – Demographic, lifestyle, diagnostic etc.
  4. Storage requirements – Specimen can be stored as per your protocol or shipped as per your instructions.